首页 › 基金 › INFINITUM ASSET MANAGEMENT, LLC › BNTC
INFINITUM ASSET MANAGEMENT, LLC 对 BNTC 的持仓历史
BENITEC BIOPHARMA INC · 医疗保健
INFINITUM ASSET MANAGEMENT, LLC 在 Q2 2026 的 13F 申报中披露持有 BNTC(BENITEC BIOPHARMA INC)923,006 股,市值约 US$12.3M,约占其申报组合的 1.26%,在其申报持仓中市值排名第 13 位。 INFINITUM ASSET MANAGEMENT, LLC 最近 7 个申报季度中有 7 个季度披露了 BNTC 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
INFINITUM ASSET MANAGEMENT, LLC 对 BNTC 的持仓演变
INFINITUM ASSET MANAGEMENT, LLC 于 Q4 2024 首次披露 BNTC 持仓:210,000 股(约 US$2.7M)。 该持仓在 Q1 2025 达到峰值 1,125,000 股,市值约 US$18.9M。 在 7 次申报中,INFINITUM ASSET MANAGEMENT, LLC 3 次增持、1 次减持、2 次保持不变。 最近一期申报(Q2 2026)显示持股 923,006 股、市值约 US$12.3M。 持仓曾出现大幅变动:Q1 2025 增持约 436% (随后一个季度股价下跌 10%)、Q2 2025 减持约 56% (随后一个季度股价上涨 20%)、Q4 2025 增持约 80% (随后一个季度股价下跌 21%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 210.00K | $2.65M | 新进 |
| Q1 2025 | 1.12M | $18.91M | 增持 |
| Q2 2025 | 500.00K | $5.85M | 减持 |
| Q3 2025 | 500.00K | $7.01M | 持有 |
| Q4 2025 | 898.87K | $12.11M | 增持 |
| Q1 2026 | 923.01K | $9.83M | 增持 |
| Q2 2026 | 923.01K | $12.35M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BNTC 与 13F 数据
BNTC(BENITEC BIOPHARMA INC)属于医疗保健行业。我们追踪的基金中还有 56 只申报持有 BNTC,申报仓位最大的包括:MONTANOVA CAPITAL, LLC (US$154.5M), Nantahala Capital Management, LLC (US$19.9M), Simplify Asset Management Inc. (US$13.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BNTC 的基金
- MONTANOVA CAPITAL, LLC 11.55M 股 · $154.52M · Q2 2026
- Nantahala Capital Management, LLC 1.49M 股 · $19.91M · Q2 2026
- Simplify Asset Management Inc. 1.01M 股 · $13.45M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 679.83K 股 · $9.10M · Q2 2026
- MYDA Advisors LLC 250.00K 股 · $3.35M · Q2 2026
- Lion Point Capital, LP 62.00K 股 · $829.56K · Q2 2026
更多关于 INFINITUM ASSET MANAGEMENT, LLC
常见问题
How long has INFINITUM ASSET MANAGEMENT, LLC held BNTC?
INFINITUM ASSET MANAGEMENT, LLC has disclosed BNTC holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is INFINITUM ASSET MANAGEMENT, LLC's current position in BNTC?
As of Q2 2026, INFINITUM ASSET MANAGEMENT, LLC holds 923.01K shares of BNTC (BENITEC BIOPHARMA INC), valued at $12.35M, representing 1.26% of its reported portfolio and ranking #13.
Has INFINITUM ASSET MANAGEMENT, LLC been buying or selling BNTC?
In the latest 13F filing (Q2 2026), INFINITUM ASSET MANAGEMENT, LLC held unchanged its position in BNTC. The position peaked in Q1 2025 at 1.12M shares.
Which other funds hold BNTC?
Other major institutional holders of BNTC include MONTANOVA CAPITAL, LLC, Nantahala Capital Management, LLC, Simplify Asset Management Inc., among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.